Evotec’s cutting-edge proteomics and metabolomics platforms harness high-throughput, quantitative mass spectrometry to accelerate data-driven drug discovery. With over 20 years of expertise and a robust infrastructure of more than 50 mass spectrometry instruments, Evotec delivers unparalleled precision, scalability, and depth, profiling over 10,000 proteins and 40,000 post-translational modifications. From early target identification to clinical biomarker validation, Evotec’s integrated workflows and advanced bioinformatics empower pharmaceutical innovation across the entire R&D pipeline.